|
Market Closed -
Other stock markets
|
After hours 06:32:49 am | |||
| 760.66 USD | +0.19% |
|
743.88 | -2.21% |
| Market Cap | 75.81B 65.83B 61.38B 56.38B 107B 7,212B 108B 724B 283B 3,605B 285B 278B 11,945B | P/E 2026 * |
17.7x | P/E 2027 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 68.95B 59.87B 55.82B 51.28B 96.98B 6,558B 98.04B 658B 257B 3,278B 259B 253B 10,863B | EV / Sales 2026 * |
4.08x | EV / Sales 2027 * | 3.56x |
| Free-Float |
71.07% | Yield 2026 * |
0.51% | Yield 2027 * | 0.58% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.19% | ||
| 1 week | +9.42% | ||
| Current month | -0.26% | ||
| 1 month | +17.06% | ||
| 3 months | +7.25% | ||
| 6 months | -1.86% | ||
| Current year | -1.45% |
| 1 week | 691 | 772.75 | |
| 1 month | 637.72 | 772.75 | |
| Current year | 591.52 | 821.11 | |
| 1 year | 541 | 821.11 | |
| 3 years | 476.49 | 1,211.2 | |
| 5 years | 476.49 | 1,211.2 | |
| 10 years | 271.37 | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/7/26 | Sell | Director | -200 | 0.0002% | ||
| 19/2/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 9/2/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.19% | +9.42% | +33.09% | -0.75% | 75.81B | ||
| +0.86% | -9.15% | +20.80% | +181.80% | 48.57B | ||
| +3.72% | -4.47% | -7.16% | +18.96% | 46.01B | ||
| +3.64% | +10.69% | -51.21% | -51.75% | 41.66B | ||
| +3.29% | +1.38% | +57.68% | -22.49% | 29.82B | ||
| +1.83% | -7.18% | +54.54% | +89.53% | 24.01B | ||
| +3.36% | +2.12% | +106.19% | -47.32% | 22.01B | ||
| +0.81% | -2.97% | -6.77% | +164.33% | 19.09B | ||
| +0.05% | -5.99% | +64.98% | +113.20% | 15.83B | ||
| +2.64% | -4.07% | +71.87% | +162.62% | 15.63B | ||
| Average | +2.12% | -0.47% | +34.40% | +60.81% | 33.84B | |
| Weighted average by Cap. | +1.98% | +1.74% | +24.95% | +45.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.89B 14.66B 13.67B 12.56B 23.75B 1,606B 24.02B 161B 63.01B 803B 63.42B 62.03B 2,661B | 18.34B 15.92B 14.85B 13.64B 25.8B 1,745B 26.08B 175B 68.43B 872B 68.87B 67.36B 2,890B |
| Net income | 4.61B 4B 3.73B 3.43B 6.48B 438B 6.55B 43.97B 17.19B 219B 17.3B 16.92B 726B | 5.35B 4.65B 4.33B 3.98B 7.53B 509B 7.61B 51.09B 19.97B 255B 20.1B 19.66B 843B |
| Net Debt | -6.87B -5.96B -5.56B -5.11B -9.66B -653B -9.77B -65.56B -25.63B -327B -25.79B -25.23B -1,082B | -10.55B -9.16B -8.54B -7.85B -14.84B -1,004B -15.01B -101B -39.38B -502B -39.63B -38.76B -1,663B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | USD 760.66 | +0.19% | 804,434 |
| 03/08/26 | USD 759.24 | -0.44% | 842,730 |
| 31/07/26 | USD 762.63 | +3.29% | 1,158,583 |
| 30/07/26 | USD 738.34 | +6.17% | 1,460,963 |
| 29/07/26 | USD 695.42 | +0.03% | 1,022,421 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions


















